EMA publishes GMP non-compliance data

Statement of non-compliance is a documentation that is issued by the inspectors, when they conclude that a particular site under inspection is not compliant. This occurs when the inspectors of regulatory authorities conduct inspection at manufacturing plants and facilities of drug companies.
If a site is complaint with GMP, a GMP certification is issued, whereas when the site is found deficient the non-compliance statement is issued. This document is entered in EudraGMP by the regulatory authorities. From now onwards, the information and such statements of non-compliance as well as positive GMP certificates would be available and publicly accessible. In the year 2013, there were around 34 reports of GMP non-compliance and most of the plants were based in India and China.